IPO registrations (S-1, F-1) · Registrants
Cibus, Inc.
- SEC CIK
- 1705843 · filings on EDGAR ↗
- Name on the registration
- Calyxt, Inc.
- Former names
- Calyxt, Inc. (2017–2023)
- Registration
- Form S-1, first filed 2017-06-23, last 2018-05-15; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2017-07-21; declared effective 2017-07-19
- Industry (SIC)
- Agricultural Chemicals 2870
- Incorporated in
- DE
- Business address
- 6455 NANCY RIDGE DRIVE, San Diego, CA 92121
- EIN
- 27-1967997
- Ticker
- CBUS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Cibus, Inc. on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2017-07-19)
- Final price
- $8.00 per share, within the range (424B4 filed 2017-07-21, an initial public offering)
- Shares sold
- 7,000,000
- Gross proceeds
- $56,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CLXT
- Lead underwriters
- Citigroup; Jefferies
- Syndicate
- Wells Fargo; BMO Capital Markets; Ladenburg Thalmann
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Cibus, Inc. Fuzzy (name and state)
- Form 5500 plan sponsor: CALYXT, INC. EXACT (EIN (EXACT))
- Form D issuer: Calyxt, Inc. EXACT (CIK (EXACT))
- SEC filer: Calyxt, Inc. EXACT (CIK (EXACT))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-06-23 | S-1 | S-1 (registration) | Calyxt, Inc. | 0001193125-17-211349 ↗ |
| 2017-07-03 | S-1/A | S-1/A (amendment) | Calyxt, Inc. | 0001193125-17-221262 ↗ |
| 2017-07-10 | S-1/A | S-1/A (amendment) | Calyxt, Inc. | 0001193125-17-224737 ↗ |
| 2017-07-19 | S-1/A | S-1/A (amendment) | Calyxt, Inc. | 0001193125-17-231103 ↗ |
| 2017-07-19 | EFFECT | EFFECT (declared effective) | Calyxt, Inc. | 9999999995-17-001859 ↗ |
| 2017-07-21 | 424B4 | 424B4 (final prospectus) | Calyxt, Inc. | 0001193125-17-232854 ↗ |
| 2018-05-15 | S-1 | S-1 (registration) | Calyxt, Inc. | 0001193125-18-164168 ↗ |
| 2018-05-17 | EFFECT | EFFECT (declared effective) | Calyxt, Inc. | 9999999995-18-001284 ↗ |
| 2018-05-18 | S-1MEF | S-1MEF (added securities) | Calyxt, Inc. | 0001193125-18-167098 ↗ |
| 2018-05-21 | 424B1 | 424B1 (final prospectus) | Calyxt, Inc. | 0001193125-18-169632 ↗ |
| 2019-09-27 | EFFECT | EFFECT (declared effective) | Calyxt, Inc. | 9999999995-19-002193 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-07-19 | S-1/A | registration statement | $8.00–$10.00 | 6,060,606 | - | Nasdaq CLXT | 5 | primary document; range, shares headline, cover names 5 | document ↗ | |
| 2017-07-21 | 424B4 | final prospectus | $8.00 | 7,000,000 | $56,000,000 | Nasdaq CLXT | 5 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Arbadji Michel | Officer | Director of Bus. Development; Director of Business Developme | 4 | 2017–2018 | |
| Arthaud Laurent | Director | 3 | 2017–2020 | ||
| Bowers Glenn R | Officer | Vice President of Breeding | 3 | 2017–2018 | |
| Cellectis S.A. | TenPercentOwner | 4 | 2017–2020 | ||
| Choulika Andre | Director | 7 | 2017–2020 | ||
| Corkal Bryan W.J. | Officer | Chief Financial Officer | 4 | 2017–2018 | |
| Dumont Philippe | Director | 16 | 2017–2023 | ||
| Godard Alain | Director | 5 | 2017–2018 | ||
| Kozicz-Stankiewicz Anna Ewa | Director | 12 | 2017–2023 | ||
| Sahoo Manoj | Officer | Chief Commercial Officer | 11 | 2017–2019 | |
| Saluri Joseph | Officer | General Counsel, EVP-Corp Dev | 1 | 2017 | |
| Tripodi Federico A. | Officer | Chief Executive Officer | 2 | 2017–2018 | |
| Voytas Daniel F | Officer | Chief Science Officer | 28 | 2017–2021 | |
| Zhang Feng | Officer | Chief Operations Officer | 1 | 2017 | |
| Dutang Eric | Officer | Chief Financial Officer | 1 | 2018 | |
| Ribeill Yves J | Director; Director,Officer | Executive Chair | 16 | 2018–2023 | |
| Jonathan Fassberg | Director | 8 | 2018–2023 | ||
| NEUGENT CHRISTOPHER J | Director | 11 | 2018–2023 | ||
| Blome James | Officer | Chief Executive Officer | 13 | 2018–2021 | |
| Koschak William | Officer | Chief Financial Officer | 17 | 2019–2023 | |
| Nelson Kimberly K. | Director | 6 | 2019–2023 | ||
| Frimerman Debra H | Officer | General Counsel; General Counsel and Secretary | 14 | 2019–2023 | |
| Frey Travis | Officer | Chief Technology Officer; Chief Technology Officer | 27 | 2019–2023 | |
| Reiter Sarah | Officer | Chief Business Officer | 2 | 2021 | |
| Carr Michael A. | Director,Officer; Officer | President and CEO | 10 | 2021–2023 | |
| Beetham Peter | Director,Officer; Officer | Interim CEO, Pres & COO; President and CEO; President and COO; See Remarks | 6 | 2023–2026 | |
| Finn Mark Terrence | Director; Director,TenPercentOwner | 6 | 2023–2026 | ||
| Gocal Gregory Francis William | Officer | Chief Scientific Officer & EVP; See Remarks | 8 | 2023–2026 | |
| King Wade Hampton | Officer | Chief Financial Officer | 2 | 2023 | |
| Lehmann Jean-Pierre Jules | Director | 8 | 2023–2026 | ||
| Prante Gerhard | Director | 58 | 2023–2026 | ||
| RIGGS RORY B | Director; Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer | 14 | 2023–2026 | |
| Walker Keith Allen | Director | 4 | 2023–2025 | ||
| Finn Jonathan | TenPercentOwner | 2 | 2023 | ||
| Collins James C. Jr. | Director | 1 | 2023 | ||
| Broos Carlo | Officer | CFO; Interim CFO | 8 | 2024–2026 | |
| Moretti August J | Director | 4 | 2024–2026 | ||
| Sauer Noel | Officer | Sr VP, Research; SVP, Research | 5 | 2025–2026 | |
| Stokes Jason | Officer | CAO, Gen Csl & Corp Secy; CLO, Gen Csl & Secy | 5 | 2025–2026 | |
| Box Kimberly Ann | Director | 3 | 2025–2026 | ||
| Wichner Craig | Director; Officer | CEO | 4 | 2025–2026 | |
| Urban Thomas | Director | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-06-29 | Calyxt, Inc. | Agriculture | Indefinite | $47,486,148 | 48 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Calyxt, Inc. | MN | Form D private offerings | CIK (EXACT) |
| SEC filer | Cibus, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Cibus, Inc. | State business registries | name and state | |
| Form 5500 plan sponsor | CALYXT, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Agricultural Chemicals, CA first:
- AGRAQUEST INC CA
- AMERICAN SOIL TECHNOLOGIES INC CA
- Pro Farm Group, Inc. CA
- Purebase Corp CA
- MED-X, INC. CA
- SenesTech, Inc. AZ
- Bioceres S.A. C1
- UAP HOLDING CORP CO
- Bioceres Crop Solutions Corp. E9
- China Yingxia International, Inc. F4
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Agricultural Chemicals · Health